(Q43858846)

English

Clinical pharmacodynamics of continuous-infusion etoposide

scientific article published in January 1990

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Clinical pharmacodynamics of continuous-infusion etoposide (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

A A Miller

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

C F Stewart

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

E A Tolley

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

publication date

1 January 1990

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

25

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

361-366

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

https://scigraph.springernature.com/pub.10.1007/bf00686238

0 references

Survival and cycle-progression delay of human lymphoma cells in vitro exposed to VP-16-213

1 reference

https://pubmed.ncbi.nlm.nih.gov/2155063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vitro pharmacodynamic evaluation of VP-16-213 and implications for chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/2155063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adaptive control of etoposide administration: impact of interpatient pharmacodynamic variability.

1 reference

https://pubmed.ncbi.nlm.nih.gov/2155063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2155063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Etoposide: an update

1 reference

https://pubmed.ncbi.nlm.nih.gov/2155063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical pharmacodynamics of continuous infusion teniposide: systemic exposure as a determinant of response in a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/2155063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of numerical integrating algorithms by trapezoidal, Lagrange, and spline approximation

1 reference

https://pubmed.ncbi.nlm.nih.gov/2155063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schedule dependency of the antileukemic activity of the podophyllotoxin-derivative VP 16-213 (NSC-141540) in L1210 leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/2155063

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00686238

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43858846&oldid=2143958150"